To obtain further, and more focused, information on the efficacy and safety of the antithrombotic regimens, including triple therapy (TT) of warfarin, aspirin, and clopidogrel; dual therapy (DT) of warfarin and single antiplatelet agent (aspirin or clopidogrel); and dual-antiplatelet therapy (DAPT) of aspirin and clopidogrel, prescribed to patients on oral anticoagulation (OAC) undergoing percutaneous coronary intervention with stent (PCI-S).
Outcome of patients on oral anticoagulation undergoing coronary artery stenting: data from discharge to 12 months in the Warfarin and Coronary Stenting (WAR-STENT) Registry / Rubboli, Andrea; Saia, Francesco; Sciahbasi, Alessandro; Bacchi-Reggiani, Maria Letizia; Steffanon, Luigi; Briguori, Carlo; Calabrò, Paolo; Palmieri, Cataldo; Rizzi, Andrea; Imperadore, Ferdinando; Sangiorgi, Giuseppe M; Valgimigli, Marco; Carosio, Giuseppe; Steffenino, Giuseppe; Galvani, Marcello; Di Pasquale, Giuseppe; La Vecchia, Luigi; Maggioni, Aldo P; Bolognese, Leonardo. - In: THE JOURNAL OF INVASIVE CARDIOLOGY. - ISSN 1557-2501. - STAMPA. - 26:11(2014), pp. 563-569.
Outcome of patients on oral anticoagulation undergoing coronary artery stenting: data from discharge to 12 months in the Warfarin and Coronary Stenting (WAR-STENT) Registry
SAIA, FRANCESCO;BACCHI REGGIANI, MARIA LETIZIA;
2014
Abstract
To obtain further, and more focused, information on the efficacy and safety of the antithrombotic regimens, including triple therapy (TT) of warfarin, aspirin, and clopidogrel; dual therapy (DT) of warfarin and single antiplatelet agent (aspirin or clopidogrel); and dual-antiplatelet therapy (DAPT) of aspirin and clopidogrel, prescribed to patients on oral anticoagulation (OAC) undergoing percutaneous coronary intervention with stent (PCI-S).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
